PDX1 and neoplasm: When PBPC products with 10% contaminating neuroblastoma cells were used, we observed that an increase of 25 ± 1% of the main transducer voltage relative to calibration settings resulted in a relative recovery of 98.4 ± 0.47% of PDX-1 cells in the center (tumor cell) outlet.